Neural Therapeutics Inc. (CSE:NURL)
Canada flag Canada · Delayed Price · Currency is CAD
0.0200
+0.0050 (33.33%)
At close: Aug 19, 2026

Neural Therapeutics Ratios and Metrics

Millions CAD. Fiscal year is Aug - Jul.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22
32---
Market Cap Growth
-33.14%----
Enterprise Value
43---
Last Close Price
0.020.03---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22
PB Ratio
5.18-3.05---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22
Debt / Equity Ratio
1.23-1.02-0.56-0.53-
Net Debt / Equity Ratio
1.14-0.80-0.460.5139.29
Quick Ratio
0.380.980.310.720.91
Current Ratio
0.391.100.310.740.98
Return on Assets (ROA)
-50.56%-422.30%-183.08%-186.98%-
Return on Capital Employed (ROCE)
-61.00%-5824.00%311.30%982.80%7830.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Jul '25 Jul '24 Jul '23 Jul '22
Earnings Yield
-37.38%-46.27%---
Buyback Yield / Dilution
-87.15%-19.37%-58.39%-7.98%-